SPADH
gene geneOn this page
Summary
SPADH (spermadhesin family member, HGNC:55808) is a protein-coding gene on chromosome 10q26.13, encoding CUB domain-containing protein (A0A494C103).
At a glance
- MANE Select transcript:
NM_001364461
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:55808 |
| Approved symbol | SPADH |
| Name | spermadhesin family member |
| Location | 10q26.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000286135 |
| Ensembl biotype | protein_coding |
| Entrez | 112577516 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000652090
RefSeq mRNA: 1 — MANE Select: NM_001364461
NM_001364461
CCDS: CCDS91369
Canonical transcript exons
ENST00000652090 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003843119 | 122675641 | 122675670 |
| ENSE00003843463 | 122672850 | 122672927 |
| ENSE00003848092 | 122676756 | 122676891 |
| ENSE00003848564 | 122678847 | 122679494 |
Expression profiles
Bgee: expression breadth broad, 11 present calls, max score 57.44.
Top tissues by expression
123 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| colonic epithelium | UBERON:0000397 | 57.44 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 39.06 | gold quality |
| ventricular zone | UBERON:0003053 | 36.48 | gold quality |
| cortical plate | UBERON:0005343 | 36.47 | gold quality |
| bone marrow cell | CL:0002092 | 36.16 | gold quality |
| ganglionic eminence | UBERON:0004023 | 35.49 | gold quality |
| gall bladder | UBERON:0002110 | 35.48 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 33.38 | gold quality |
| tonsil | UBERON:0002372 | 33.03 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 32.15 | gold quality |
| skin of abdomen | UBERON:0001416 | 31.93 | gold quality |
| bone marrow | UBERON:0002371 | 31.74 | gold quality |
| muscle tissue | UBERON:0002385 | 31.06 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| monocyte | CL:0000576 | 30.05 | gold quality |
| stromal cell of endometrium | CL:0002255 | 29.87 | gold quality |
| leukocyte | CL:0000738 | 29.83 | gold quality |
| prefrontal cortex | UBERON:0000451 | 29.24 | gold quality |
| zone of skin | UBERON:0000014 | 29.18 | gold quality |
| liver | UBERON:0002107 | 28.52 | gold quality |
| duodenum | UBERON:0002114 | 28.14 | gold quality |
| lymph node | UBERON:0000029 | 27.57 | gold quality |
| skin of leg | UBERON:0001511 | 27.11 | gold quality |
| urinary bladder | UBERON:0001255 | 26.90 | gold quality |
| islet of Langerhans | UBERON:0000006 | 26.55 | gold quality |
| vermiform appendix | UBERON:0001154 | 26.42 | gold quality |
| blood | UBERON:0000178 | 26.01 | gold quality |
| placenta | UBERON:0001987 | 25.81 | gold quality |
| right lung | UBERON:0002167 | 25.44 | gold quality |
| right atrium auricular region | UBERON:0006631 | 25.32 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 0.57 |
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
CUB domain-containing protein — A0A494C103 (reviewed: A0A494C103)
All UniProt accessions (1): A0A494C103
RefSeq proteins (1): NP_001351390* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000859 | CUB_dom | Domain |
| IPR035914 | Sperma_CUB_dom_sf | Homologous_superfamily |
Pfam: PF00431
UniProt features (5 total): disulfide bond 2, signal peptide 1, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A0A494C103-F1 | 87.32 | 0.75 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Disulfide bonds (2): 30–51, 75–96
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 1 (showing top):
chr10q26
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
272 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SPADH | CDCP1 | Q9H5V8 | 624 |
| SPADH | NETO1 | Q8TDF5 | 623 |
| SPADH | NETO2 | Q8NC67 | 404 |
| SPADH | SCUBE3 | Q8IX30 | 397 |
| SPADH | CD6 | P30203 | 363 |
| SPADH | CNIH1 | O95406 | 355 |
| SPADH | BMP1 | P13497 | 338 |
| SPADH | C1R | P00736 | 303 |
| SPADH | C1S | P09871 | 297 |
| SPADH | ARRDC1 | Q8N5I2 | 284 |
| SPADH | GRIK2 | Q13002 | 279 |
| SPADH | SHISA9 | B4DS77 | 272 |
| SPADH | TACSTD2 | P09758 | 259 |
| SPADH | GRIK3 | Q13003 | 258 |
| SPADH | KARS1 | Q15046 | 232 |
IntAct
0 interactions, top by confidence:
ESM2 similar proteins: A0A0A7LRQ7, A0A172M485, A0A494C103, A0A6B9L3R4, A0A888, B1A4P8, B7T7N1, C0HK14, C7YS44, D9UBG0, D9UBI3, G5ED65, H2A0L3, L0GB04, O45879, O76411, O95711, P0DKQ8, P0DQG2, P10379, P15501, P25607, P29392, P35495, P35496, P46555, P82292, P86728, P86785, P86983, P93114, P93193, Q09271, Q20170, Q21038, Q25410, Q28920, Q3T0L5, Q45KX2, Q61G93
Diamond homologs: A0A494C103, P24020, P26322, P26776, P29392, P35495, P35496, P80720, P82292, Q28920, Q4A3R3, Q60997, O70244, Q9UGM3, Q86UP6, Q8BZE1, P98069, Q15113, Q7RTZ1, Q7Z407, Q80T79, Q923L3, Q96PZ7, Q9JLB4, Q9TU53, Q9Y5Y6, Q95218
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
0 predictions. Top by Δscore:
AlphaMissense
895 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:122676830:T:A | C51S | 0.995 |
| 10:122676831:G:C | C51S | 0.995 |
| 10:122676838:G:C | W53C | 0.995 |
| 10:122676838:G:T | W53C | 0.995 |
| 10:122676830:T:C | C51R | 0.990 |
| 10:122676767:T:A | C30S | 0.988 |
| 10:122676768:G:C | C30S | 0.988 |
| 10:122676832:C:G | C51W | 0.987 |
| 10:122676836:T:A | W53R | 0.984 |
| 10:122676836:T:C | W53R | 0.984 |
| 10:122678920:T:A | C96S | 0.982 |
| 10:122678921:G:C | C96S | 0.982 |
| 10:122678969:T:A | I112N | 0.980 |
| 10:122678969:T:G | I112S | 0.979 |
| 10:122676831:G:A | C51Y | 0.977 |
| 10:122679019:T:G | Y129D | 0.977 |
| 10:122678982:A:C | R116S | 0.975 |
| 10:122678982:A:T | R116S | 0.975 |
| 10:122678867:A:T | E78V | 0.973 |
| 10:122679008:T:G | F125C | 0.973 |
| 10:122676794:G:T | G39C | 0.970 |
| 10:122676801:T:C | I41T | 0.970 |
| 10:122678921:G:A | C96Y | 0.970 |
| 10:122679014:T:A | I127K | 0.970 |
| 10:122676767:T:C | C30R | 0.969 |
| 10:122676768:G:A | C30Y | 0.969 |
| 10:122676769:T:G | C30W | 0.968 |
| 10:122678866:G:A | E78K | 0.968 |
| 10:122678975:A:G | Y114C | 0.968 |
| 10:122678857:T:A | C75S | 0.967 |
dbSNP variants (sampled 300 via entrez): RS1000138317 (10:122679463 A>T), RS1000457698 (10:122678571 G>GA), RS1000543987 (10:122675902 G>A,C), RS1000732076 (10:122672479 G>A), RS1001248868 (10:122672939 C>G), RS1002009974 (10:122678967 C>G,T), RS1002210742 (10:122678342 T>C), RS1002240299 (10:122672864 T>C,G), RS1002251254 (10:122674611 A>G), RS1002865029 (10:122674158 T>C), RS1002889770 (10:122671984 T>C), RS1002920961 (10:122671687 C>T), RS1003857279 (10:122677274 T>G), RS1004391658 (10:122677801 G>A), RS1005105249 (10:122676262 A>C)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.